BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24828903)

  • 1. Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review.
    Maroni L; van de Graaf SF; Hohenester SD; Oude Elferink RP; Beuers U
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):182-91. PubMed ID: 24828903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of FUT2 and ABO with Crohn's disease in Koreans.
    Ye BD; Kim BM; Jung S; Lee HS; Hong M; Kim K; Moon JW; Baek J; Oh EH; Hwang SW; Park SH; Yang SK; Song K
    J Gastroenterol Hepatol; 2020 Jan; 35(1):104-109. PubMed ID: 31260595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic expression of blood type antigens in inflamed mucosa with higher incidence of FUT2 secretor status in colonic Crohn's disease.
    Miyoshi J; Yajima T; Okamoto S; Matsuoka K; Inoue N; Hisamatsu T; Shimamura K; Nakazawa A; Kanai T; Ogata H; Iwao Y; Mukai M; Hibi T
    J Gastroenterol; 2011 Sep; 46(9):1056-63. PubMed ID: 21725903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease.
    McGovern DP; Jones MR; Taylor KD; Marciante K; Yan X; Dubinsky M; Ippoliti A; Vasiliauskas E; Berel D; Derkowski C; Dutridge D; Fleshner P; Shih DQ; Melmed G; Mengesha E; King L; Pressman S; Haritunians T; Guo X; Targan SR; Rotter JI;
    Hum Mol Genet; 2010 Sep; 19(17):3468-76. PubMed ID: 20570966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis.
    Rupp C; Friedrich K; Folseraas T; Wannhoff A; Bode KA; Weiss KH; Schirmacher P; Sauer P; Stremmel W; Gotthardt DN
    Aliment Pharmacol Ther; 2014 Apr; 39(8):873-82. PubMed ID: 24612312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection.
    Haga K; Ettayebi K; Tenge VR; Karandikar UC; Lewis MA; Lin SC; Neill FH; Ayyar BV; Zeng XL; Larson G; Ramani S; Atmar RL; Estes MK
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of the primary sclerosing cholangitis-risk gene Fut2 causes liver disease in mice.
    Maroni L; Hohenester SD; van de Graaf SFJ; Tolenaars D; van Lienden K; Verheij J; Marzioni M; Karlsen TH; Oude Elferink RPJ; Beuers U
    Hepatology; 2017 Aug; 66(2):542-554. PubMed ID: 28056490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of FUT2 (rs601338) with celiac disease and inflammatory bowel disease in the Finnish population.
    Parmar AS; Alakulppi N; Paavola-Sakki P; Kurppa K; Halme L; Färkkilä M; Turunen U; Lappalainen M; Kontula K; Kaukinen K; Mäki M; Lindfors K; Partanen J; Sistonen P; Mättö J; Wacklin P; Saavalainen P; Einarsdottir E
    Tissue Antigens; 2012 Dec; 80(6):488-93. PubMed ID: 23075394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior.
    Forni D; Cleynen I; Ferrante M; Cassinotti A; Cagliani R; Ardizzone S; Vermeire S; Fichera M; Lombardini M; Maconi G; de Franchis R; Asselta R; Biasin M; Clerici M; Sironi M
    J Crohns Colitis; 2014 Jun; 8(6):489-94. PubMed ID: 24268527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.
    Folseraas T; Melum E; Rausch P; Juran BD; Ellinghaus E; Shiryaev A; Laerdahl JK; Ellinghaus D; Schramm C; Weismüller TJ; Gotthardt DN; Hov JR; Clausen OP; Weersma RK; Janse M; Boberg KM; Björnsson E; Marschall HU; Cleynen I; Rosenstiel P; Holm K; Teufel A; Rust C; Gieger C; Wichmann HE; Bergquist A; Ryu E; Ponsioen CY; Runz H; Sterneck M; Vermeire S; Beuers U; Wijmenga C; Schrumpf E; Manns MP; Lazaridis KN; Schreiber S; Baines JF; Franke A; Karlsen TH
    J Hepatol; 2012 Aug; 57(2):366-75. PubMed ID: 22521342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients.
    Gaj P; Habior A; Mikula M; Ostrowski J
    BMC Med Genet; 2008 Aug; 9():81. PubMed ID: 18715515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
    J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric intrinsic factor deficiency with combined GIF heterozygous mutations and FUT2 secretor variant.
    Chery C; Hehn A; Mrabet N; Oussalah A; Jeannesson E; Besseau C; Alberto JM; Gross I; Josse T; Gérard P; Guéant-Rodriguez RM; Freund JN; Devignes J; Bourgaud F; Peyrin-Biroulet L; Feillet F; Guéant JL
    Biochimie; 2013 May; 95(5):995-1001. PubMed ID: 23402911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis.
    Zetterquist H; Broomé U; Einarsson K; Olerup O
    Gut; 1992 Jul; 33(7):942-6. PubMed ID: 1644334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism.
    Tong M; McHardy I; Ruegger P; Goudarzi M; Kashyap PC; Haritunians T; Li X; Graeber TG; Schwager E; Huttenhower C; Fornace AJ; Sonnenburg JL; McGovern DP; Borneman J; Braun J
    ISME J; 2014 Nov; 8(11):2193-206. PubMed ID: 24781901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal microbiota composition in adults is associated with the FUT2 gene determining the secretor status.
    Wacklin P; Tuimala J; Nikkilä J; Sebastian Tims ; Mäkivuokko H; Alakulppi N; Laine P; Rajilic-Stojanovic M; Paulin L; de Vos WM; Mättö J
    PLoS One; 2014; 9(4):e94863. PubMed ID: 24733310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using GWAS to identify genetic predisposition in hepatic autoimmunity.
    Webb GJ; Hirschfield GM
    J Autoimmun; 2016 Jan; 66():25-39. PubMed ID: 26347073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
    Seibold F; Slametschka D; Gregor M; Weber P
    Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiome Composition and Metabolic Capacity Differ by
    Thorman AW; Adkins G; Conrey SC; Burrell AR; Yu Y; White B; Burke R; Haslam D; Payne DC; Staat MA; Morrow AL; Newburg DS
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the fucosyltransferase 2 (FUT2) secretor status in children hospitalized with acute gastroenteritis in Taiwan.
    Lin HY; Lai HH; Elaine Chen YF; Chao HC; Tsai CN; Chang YJ; Chen SY
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):212-216. PubMed ID: 32448707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.